When did Prime Medicine report Q4 2024 earnings?

Prime Medicine (PRME) reported Q4 2024 earnings on February 28, 2025 before market open.

What were Prime Medicine's Q4 2024 revenue and EPS?

Prime Medicine reported revenue of $2.2M and eps of $-0.31 for Q4 2024.

Did Prime Medicine beat estimates in Q4 2024?

Revenue missed the consensus estimate of $6.8M by $4.6M. EPS beat the consensus estimate of $-0.37 by $0.06.

Where can I find Prime Medicine's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001628280-25-008884) directly on SEC EDGAR. The filing index links above go to sec.gov.

Prime Medicine PRME Q4 2024 Annual earnings

Reported February 28, 2025 · Before market open

Revenue$2.2MMiss by $4.6M

EPS-$0.31Beat by $0.06

Revenue estimate$6.8M

EPS estimate-$0.37

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$2.3M

EPS estimate-$0.24

Financials

Q4 2024

Income statement

See full

Revenue$2.2M—

Operating income-$44.2M+35.0%

Net income-$42.3M+35.6%

EPS (diluted)-$0.31+56.9%

Balance sheet

See full

Cash & equivalents$196.5M+257%

Total debt$40.8M+199%

Total equity$153.1M+15.1%

Total assets$297.5M+53.5%

Cash flow

See full

CapEx$1.8M-2.7%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$382.99M-55.6%

Enterprise value$227.25M-72.3%

P/S128.4×—

Profitability

See full

Operating margin-6,787.4%—

Net margin-6,566.6%—

Returns & leverage

See full

Return on equity-136.9%+169pp

Debt / equity0.3×+0.2×

Current ratio5.6×+3.0×

Segments

By segment

See full

Reportable Segment$2.2M—

Versus estimates

Revenue

Q1 2026$856.0KMiss by $1.5M Q4 2025$842.0KMiss by $445.4K Q3 2025$1.2MMiss by $826.3K Q2 2025$1.1MMiss by $1.7M Q1 2025$1.5MMiss by $879.3K

Q4 2024$2.2MMiss by $4.6M

Diluted EPS

Q1 2026-$0.28Miss by $0.04 Q4 2025-$0.22Beat by $0.03 Q3 2025-$0.32Miss by $0.04 Q2 2025-$0.41Miss by $0.05 Q1 2025-$0.40Miss by $0.08

Q4 2024-$0.31Beat by $0.06

Ask the moment Prime Medicine reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Prime Medicine report Q4 2024 earnings?: Prime Medicine (PRME) reported Q4 2024 earnings on February 28, 2025 before market open.
What were Prime Medicine's Q4 2024 revenue and EPS?: Prime Medicine reported revenue of $2.2M and eps of $-0.31 for Q4 2024.
Did Prime Medicine beat estimates in Q4 2024?: Revenue missed the consensus estimate of $6.8M by $4.6M. EPS beat the consensus estimate of $-0.37 by $0.06.
Where can I find Prime Medicine's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001628280-25-008884) directly on SEC EDGAR. The filing index links above go to sec.gov.